The Swedish Institute 
for Health Economics
Box 2127
S-220 02 Lund 
Visiting address: 
Råbygatan 2 
Phone: +46 46 - 32 91 00
info@ihe.se
Cost-effectiveness of dasatinib versus high-dose imatinib in patients with Chronic Myeloid Leukemia (CML), resistant to standard dose imatinib - a Swedish model application

Ghatnekar O, Hjalte F &Taylor M


Acta Oncol. 2010 Aug; 49(6): 851-8

More information
Contact:
Ola Ghatnekar
E-mail: og@ihe.se
Tel: +46 46-32 91 00




© IHE 2011